Approval · Notice of Compliance 985 · 2000
AGRYLIN: Notice of Compliance 985
Issued January 24, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 985
- Date
- January 24, 2000
- Company
- Roberts Pharmaceutical Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: treatment of thrombocythemia secondary to myeloproliferative disorders
- Therapeutic class
- Platelet-reducing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AGRYLIN | Not yet assigned | — |
Medicinal ingredients
- ANAGRELIDE HYDROCHLORIDE 0.5 MG per CAP
- ANAGRELIDE HYDROCHLORIDE 1 MG per CAP